Treatment of PBMCs with recombinant IFNγ or IL-10 in vitro caused upregulation of LAMR1 on monocytes of healthy individuals and patients with active RA in a time dependent manner (Fig. 3). The gene discussed is IL10; the disease is rheumatoid arthritis.